9-substituted minocycline compounds
US8048867B2 · kind B2 · utility
3Cited by
75References
42Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 4, 2004 |
| Grant date | Nov 1, 2011 |
| Priority date | — |
| Expiry date | Apr 12, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention pertains, at least in part, to novel 9-substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.